Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your Favorites.
This session is in your Favorites. Click again to remove it.
Presentation Icons
ACG Award Winner
ACG Newsworthy Abstract
Registration Required
No CME
On-Demand Video
Livestream
Back
Favorite
Post (Tweet)
Miguel Regueiro, MD
Cleveland Clinic
Poster(s):
P2690 - Impact of Mirikizumab on Clinically Meaningful Improvements in Fatigue as Measured by FACIT-F in Patients With Moderately to Severely Active Crohn’s Disease
Monday, October 28, 2024
10:30 AM – 4:00 PM
ET
P2691 - Improvement in Fatigue With Mirikizumab Therapy and Associations With Clinical Outcomes in Patients With Moderately to Severely Active Crohn’s Disease: Results From the PHASE 3 VIVID-1 Study
Monday, October 28, 2024
10:30 AM – 4:00 PM
ET
P4257 - Disease Characterization and Safety Contextualization in Patients with Ulcerative Colitis Using a Healthcare Administrative Database in the United States
Tuesday, October 29, 2024
10:30 AM – 4:00 PM
ET